Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2000
08/17/2000WO2000047243A2 Pancreatic ductal trophic factors, uses and composition related thereto
08/17/2000WO2000047237A1 Encapsulated cells containing an amplified expression vector as a drug delivery device
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047223A2 Viral vaccine
08/17/2000WO2000047221A1 Antiangiogenic drugs
08/17/2000WO2000047220A1 Controlling protein levels in eucaryotic organisms
08/17/2000WO2000047219A2 Methods and reagents for treating glucose metabolic disorders
08/17/2000WO2000047216A1 Immunogenic compositions for use as vaccines
08/17/2000WO2000047102A2 COMPOSITIONS AND METHODS FOR MODULATING TGF-β SIGNALING
08/17/2000WO2000038654B1 Synthetic and therapeutic methods for the alpha and beta domains of metallothionein
08/17/2000WO2000037649A3 Dna vaccine against infectious bursal disease virus
08/17/2000WO2000034473A3 Seven transmembrane domain receptor zsig56
08/17/2000WO2000034317A3 Method for reducing immunogenicity of proteins
08/17/2000WO2000033791A3 Co-factors for trophic factors, and methods of use thereof
08/17/2000WO2000032629A3 Antiviral peptides
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000026375A3 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
08/17/2000WO2000026374A3 Adipose specific protein
08/17/2000WO2000024769A3 Process for recovering heterologous polypeptide from bacterial refractile particles
08/17/2000WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
08/17/2000WO2000023463A3 Fluorescent dye binding peptides
08/17/2000WO2000021574A3 Site-directed dual pegylation of proteins
08/17/2000WO2000018912A3 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
08/17/2000WO2000017356A3 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
08/17/2000WO2000016708A9 Methods and systems for treating breast tissue
08/17/2000WO2000015816A9 Maize replication protein a
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO2000015665A3 A method of producing a functional immunoglobulin superfamily protein
08/17/2000WO2000014263A3 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000WO2000012711A3 Human membrane channel proteins
08/17/2000WO2000011157A9 Dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy
08/17/2000WO1999064594A3 Genes and gene expression products that are differentially regulated in prostate cancer
08/17/2000WO1998015626A3 Mutant ciita molecule and uses thereof
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000DE19904650A1 cDNA-Sequenz eines Interaktors FANCIP1 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequence of an interactor FANCIP1 of the Fanconi anemia complementation group A protein
08/17/2000DE19855489A1 New nucleic acid molecule comprising simian virus 40 regulatory sequences and antibiotic resistance gene, useful for expressing erythropoietin in mammalian cells for treating anemia
08/17/2000CA2364615A1 Haemophilus influenzae rd outer membrane sequences used as vaccine
08/17/2000CA2362574A1 Antiangiogenic drugs
08/17/2000CA2362560A1 Controlling protein levels in eucaryotic organisms
08/17/2000CA2362541A1 Structure-based screening techniques for drug discovery
08/17/2000CA2362524A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000CA2362368A1 Method for altering undesirable immune responses to polypeptides
08/17/2000CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000CA2362258A1 Peptides inhibiting vascular endothelial cell migration
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361334A1 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2361034A1 Proteins related to neuronal regeneration and uses thereof
08/17/2000CA2360416A1 Nac1 - a plant gene encoding a transcription factor involved in cotyledon and lateral root development
08/17/2000CA2360324A1 Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets
08/17/2000CA2360292A1 Immunogenic compositions for use as vaccines
08/17/2000CA2360123A1 Encapsulated cells containing an amplified expression vector as a drug delivery device
08/17/2000CA2360103A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
08/17/2000CA2359799A1 Neisseria meningitidis serogroup b antigen
08/17/2000CA2359757A1 Polymorphic markers of the lsr gene
08/17/2000CA2359747A1 Human uncoupling proteins and polynucleotides encoding the same
08/17/2000CA2341348A1 Improved compounds for protein binding
08/17/2000CA2297441A1 Fusion proteins comprising carriers that can induce a dual immune response
08/16/2000EP1027896A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027457A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027447A2 Methods for obtaining plant varieties
08/16/2000EP1027446A1 Materials and methods for controlling homopteran pests
08/16/2000EP1027444A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027440A1 Inhibitor protein of the wnt signal pathway
08/16/2000EP1027438A2 Novel cytokine receptors
08/16/2000EP1027437A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
08/16/2000EP1027436A1 Viral encoded semaphorin protein receptor dna and polypeptides
08/16/2000EP1027435A2 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced)
08/16/2000EP1027434A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/16/2000EP1027433A1 Human app or a4ct sequences encoding the mutation i45f
08/16/2000EP1027431A2 April- a novel protein with growth effects
08/16/2000EP1027430A1 64 human secreted proteins
08/16/2000EP1027429A1 Jnk3 modulators and methods of use
08/16/2000EP1027428A1 Alpha-amylase mutants
08/16/2000EP1027424A1 Regulators of ucp3 gene expression
08/16/2000EP1027374A1 Nucleotide sequences
08/16/2000EP1027373A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression
08/16/2000EP1027372A1 Methods, kits and compositions pertaining to linear beacons
08/16/2000EP1027371A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma
08/16/2000EP1027369A1 Methods of unfolding proteins using metal complexes
08/16/2000EP1027216A1 Bioriented polyethylene film with a high water vapor transmission rate
08/16/2000EP1027075A1 Gene therapy for stimulation of angiogenesis
08/16/2000EP1027071A2 Encapsulated immunomodulators useful as vaccine adjuvants
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000EP1027066A1 Soluble mhc complexes and methods of use thereof
08/16/2000EP1027027A2 Therapeutic method
08/16/2000EP1026949A1 Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
08/16/2000EP1026941A1 Nepovirus resistance in grapevine
08/16/2000EP0795606B1 Process for producing transformed cell
08/16/2000EP0753015B1 Monoclonal antibodies recognizing tie-receptor and their use
08/16/2000EP0668914B1 Crystallization of m-csf
08/16/2000CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells
08/16/2000CN1263555A Human TOLL-like receptor proteins, related reagents and methods
08/16/2000CN1263536A Method for detecting HIV antibodies and antigens used to this end
08/16/2000CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
08/16/2000CN1263156A New neurotrophic hormone factor, its coding sequence, its preparation and application
1 ... 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 ... 2916